Ursodeoxycholic acid inhibits ras mutations, wild type Ras activation and cyclooxygenase-2 expression in colon cancer

被引:0
|
作者
Khare, S
Cerda, S
Wali, R
Von Lintig, FC
Tretiakova, M
Stoiber, D
Cohen, G
Nimmagadda, K
Hart, J
Sitrin, M
Boss, GR
Bissonnette, M
机构
关键词
D O I
10.1016/S0016-5085(03)83066-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A605 / A605
页数:1
相关论文
共 50 条
  • [31] Orthotopic implantation of a colon cancer xenograft induces high expression of cyclooxygenase-2
    Shoji, T
    Konno, H
    Tanaka, T
    Sakaguchi, T
    Sunayama, K
    Baba, M
    Kamiya, K
    Ohta, M
    Kaneko, T
    Igarashi, A
    Nakamura, S
    [J]. CANCER LETTERS, 2003, 195 (02) : 235 - 241
  • [32] Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
    Tsujii, M
    Kawano, S
    DuBois, RN
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (07) : 3336 - 3340
  • [33] Selenomethionine inhibits growth and suppresses cyclooxygenase-2 (COX-2) protein expression in human colon cancer cell lines
    Baines, A
    Taylor-Parker, M
    Goulet, AC
    Renaud, C
    Gerner, EW
    Nelson, MA
    [J]. CANCER BIOLOGY & THERAPY, 2002, 1 (04) : 370 - 374
  • [34] Selective inhibition of cyclooxygenase-2 inhibits colon cancer cell adhesion to extracellular matrix by decreased expression of β1 integrin
    Yazawa, K
    Tsuno, NH
    Kitayama, J
    Kawai, K
    Okaji, Y
    Asakage, M
    Sunami, E
    Kaisaki, S
    Hori, N
    Watanabe, T
    Takahashi, K
    Nagawa, H
    [J]. CANCER SCIENCE, 2005, 96 (02) : 93 - 99
  • [35] Curcumin inhibits cyclooxygenase-2 (COX-2) expression in HT-29 human colon cancer cells.
    Goel, A
    Boland, CR
    Chauhan, DP
    [J]. GASTROENTEROLOGY, 1999, 116 (04) : A388 - A388
  • [36] Dysregulated PDGFR alpha expression and novel somatic mutations in colorectal cancer: association to RAS wild type status and tumor size
    Ben Jemii, Nadia
    Tounsi-Kettiti, Haifa
    Yaiche, Hamza
    Mezghanni, Najla
    Gabteni, Amira Jaballah
    Fehri, Emna
    Ben Fayala, Chayma
    Abdelhak, Sonia
    Boubaker, Samir
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [37] Dysregulated PDGFR alpha expression and novel somatic mutations in colorectal cancer: association to RAS wild type status and tumor size
    Nadia Ben Jemii
    Haifa Tounsi-Kettiti
    Hamza Yaiche
    Najla Mezghanni
    Amira Jaballah Gabteni
    Emna Fehri
    Chayma Ben Fayala
    Sonia Abdelhak
    Samir Boubaker
    [J]. Journal of Translational Medicine, 18
  • [38] Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild-type metastatic colorectal cancer: the PERSEIDA (Cohort 2) study
    Valladares-Ayerbes, Manuel
    Safont, Maria Jose
    Flores, Encarnacion Gonzalez
    Garcia-Alfonso, Pilar
    Aranda, Enrique
    Munoz, Ana-Maria Lopez
    Ferrer, Esther Falco
    Nogueras, Luis Cirera
    Rodriguez-Salas, Nuria
    Aparicio, Jorge
    Munoz, Marta Llanos
    Caceres, Paola Patricia Pimentel
    Trujillo, Oscar Alfredo Castillo
    Tocino, Rosario Vidal
    Fernandez, Mercedes Salgado
    Salud-Salvia, Antonieta
    Sureda, Bartomeu Massuti
    Garcia-Carbonero, Rocio
    Conesa, Maria Angeles Vicente
    Vila, Ariadna Lloansi
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (10): : 2640 - 2651
  • [39] Selenomethionine inhibits growth and modulates cyclooxygenase-2 (COX-2) protein expression in human colon cancer cell lines.
    Baines, AT
    Taylor, MT
    Renaud, CE
    Gerner, EW
    Nelson, MA
    [J]. CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3812S - 3812S
  • [40] Somatostatin modulates both cyclooxygenase-2 expression and proliferation in human colon cancer cells
    Colucci, R
    Blandizzi, C
    Tanini, M
    Ghisu, N
    Breschi, MC
    Del Tacca, M
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A100 - A100